Advanced Urothelial Carcinoma Clinical Trials in Guangzhou, Guangdong
3 recruitingGuangzhou, Guangdong, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Urothelial CarcinomaAdvanced Urothelial CarcinomaUrothelial Carcinoma Recurrent
Sun Yat-sen University96 enrolled6 locationsNCT07241793
Recruiting
Phase 2
Probiotics in Advanced Urothelial Carcinoma
ImmunotherapyAdvanced Urothelial CarcinomaProbiotics
Sun Yat-sen University222 enrolled3 locationsNCT06904573
Recruiting
Phase 1Phase 2
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
Advanced Urothelial Carcinoma
Shanghai Hengrui Pharmaceutical Co., Ltd.90 enrolled1 locationNCT06639347